Bonus BioGroup Ltd. (BBIXF)
OTCMKTS · Delayed Price · Currency is USD
0.1500
+0.0500 (50.00%)
At close: Feb 11, 2026
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of $189.91 million as of February 12, 2026. Its market cap has increased by 237.82% in one year.
Market Cap
189.91M
Enterprise Value
192.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 3.03M to 189.91M, an increase of 6,165.65%. That is a compound annual growth rate of 35.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 190.46M | 107.13% |
| Dec 31, 2025 | 91.95M | 140.98% |
| Dec 31, 2024 | 38.16M | -29.54% |
| Dec 31, 2023 | 54.16M | -14.96% |
| Dec 29, 2022 | 63.69M | -86.39% |
| Dec 30, 2021 | 468.10M | 211.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |